Bioprinted Organoids: An Innovative Engine in Biomedicine
Advanced Science · 2025-09 · 12 (33)
DOI: 10.1002/advs.202507317 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Science, online erschienen am 25.07.2025. Verfasst von Zhengwei Li und 11 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Metabolic Dysregulation & Prevention and Treatment of Esophageal Cancer, School of Life Sciences, Zhengzhou University, Henan…. Hauptthemen laut MEDLINE: Organoids, Bioprinting, Tissue Engineering. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 191 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program of China, Natural Science Foundation of China Original Exploration Program, Henan Provincial Science and Technology R&D Plan Joint Foundation.
Abstract (Originalsprache)
Bioprinted organoids integrate bioprinting technology with organoid research, enabling the simultaneous reconstruction of human tissue morphology and physiological function in vitro. This approach offers distinct advantages in organoid fabrication, particularly in terms of structural precision, tissue mimicry, and functional fidelity. By leveraging the complementary strengths of both technologies, bioprinted organoids allow for the fabrication of personalized, architecturally engineered models that more accurately replicate organogenesis, physiological processes, and disease progression. Herein, this review outlines the key advantages of bioprinted organoids, with a focus on their ability to precisely control morphology, dimensions, and spatial organization. Bioprinted organoids are further categorized into three types based on their cellular origins and summarize recent progress in their application for human tissue modeling. Finally, ongoing challenges and future possibilities are sketched out, offering insights for potential innovation and research directions in the field. Bioprinted organoids not only propel the advancement of organoid research but also drive the evolution of bioprinting technologies. This integrated approach represents a powerful synergy between biomanufacturing and clinical medicine to pave the way for a new era in biomedical science and personalized healthcare.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- State Key Laboratory of Metabolic Dysregulation & Prevention and Treatment of Esophageal Cancer, School of Life Sciences, Zhengzhou University, Henan, 450001, China.
- Tianjian Laboratory of Advanced Biomedical Sciences, Zhengzhou, 450001, China.
- Research Center for Human Tissue and Organ Degeneration, Institute of Biomedicine and Biotechnology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, 518055, China.
- University of Chinese Academy of Sciences, Beijing, 100049, China.
ORCID-Profile: Zhengwei Li, Changshun Ruan
Förderung
- National Key R&D Program of China
- Natural Science Foundation of China Original Exploration Program
- Henan Provincial Science and Technology R&D Plan Joint Foundation
- Henan Province Outstanding Youth Science Foundation
- China Postdoctoral Science Foundation
- Shenzhen Science and Technology Program
- Henan Province Science and Technology Research and Development Program
- Natural Science Foundation of Guangdong Province in China
Zitieren
APA
Li, Z., Li, K., Zhang, C., Zhao, Y., Guo, Y., He, J., Chang, S., Fang, X., Liu, K., Zhu, P., Chen, Z., & Ruan, C. (2025). Bioprinted Organoids: An Innovative Engine in Biomedicine. Advanced Science, 12(33). https://doi.org/10.1002/advs.202507317
Vancouver
Li Z, Li K, Zhang C, Zhao Y, Guo Y, He J, et al. Bioprinted Organoids: An Innovative Engine in Biomedicine. Advanced Science. 2025;12(33). doi:10.1002/advs.202507317
BibTeX
@article{Li2025,
author = {Li, Zhengwei and Li, Kai and Zhang, Cheng and Zhao, Yingying and Guo, Yiyuan and He, Jia and Chang, Shiyuan and Fang, Xinyi and Liu, Kaizheng and Zhu, Pingping and Chen, Zhenzhen and Ruan, Changshun},
title = {Bioprinted Organoids: An Innovative Engine in Biomedicine},
journal = {Advanced Science},
year = {2025},
volume = {12},
number = {33},
doi = {10.1002/advs.202507317}
}
EUVIMED